Agnelli and al. identified a 3-gene model of CD30/TNFRSF8, BATF3, and TMOD1 genes that separated ALK-negative ALCL from CD30+ PTCL with a 97% accuracy. This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.